Clinical Trial Update: Fixed Dose Heparin Study [Phase 3]

View source ↗

Summary

Phase 3 trial of fixed-dose heparin for venous thromboembolism, deep vein thrombosis, and pulmonary embolism has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Deep Vein Thrombosis
• Pulmonary Embolism
• Venous Thromboembolism

Drugs mentioned

• Heparin (unfractionated heparin)

Snippet

Sponsor: McMaster University | Conditions: Venous Thromboembolism, Deep Vein Thrombosis | Phase 3 | Status: COMPLETED